Skip to content
DefDex

Federal award

CANCER DIAGNOSTICS, INC.

HT001422F0024

Contract

Obligated and Ceiling

Obligated (net)
$101,000.00
Ceiling (potential value, not spending)
$101,000.00
Current value
$101,000.00
Gross positive obligations
$101,000.00

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
CANCER DIAGNOSTICS, INC. · TU4VHMALAAZ3
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
CANCER DIAGNOSTICS, INC. · TU4VHMALAAZ3
Awarding agency
Department of War · sub-agency 97DH · office HT0014
Funding agency
Department of War · sub-agency 97DH
Product or service (PSC)
6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
HT001422F0024
Parent vehicle (IDV PIID)
HT001418A0019
Award type code
A
Actions
2 · Dec 2, 2021 to Sep 13, 2022
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History2

Award actions
DateFYModAction typeObligationCompany in company totals
Sep 13, 2022FY2022P00001M$0.00
—
Dec 2, 2021FY20220—$101,000.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.